Days Inventory is also known as Days Sales of Inventory (DSI). Ionis Pharmaceuticals's Average Total Inventories for the
three
months ended in Dec. 2023 was $27.0 Mil. Ionis Pharmaceuticals's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $3.1 Mil.
Hence, Ionis Pharmaceuticals's Days Inventory for the
three
months ended in Dec. 2023 was 805.50.
The historical rank and industry rank for Ionis Pharmaceuticals's Days Inventory or its related term are showing as below:
IONS'
s Days Inventory Range Over the Past 10 Years
Min: 605.56 Med: 897.78 Max: 1861.5
Current: 989.77
During the past 13 years, Ionis Pharmaceuticals's highest Days Inventory was 1861.50. The lowest was 605.56. And the median was 897.78.
IONS's Days Inventory is ranked worse than 90.14% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs IONS: 989.77
Ionis Pharmaceuticals's Days Inventory
increased
from Dec. 2022 (528.26) to Dec. 2023 (805.50).
It might indicate that Ionis Pharmaceuticals's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ionis Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ionis Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.08.
Ionis Pharmaceuticals Days Inventory Historical Data
The historical data trend for Ionis Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Ionis Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ionis Pharmaceuticals Days Inventory Distribution
For the Biotechnology industry and Healthcare sector, Ionis Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ionis Pharmaceuticals's Days Inventory falls into.
Ionis Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Ionis Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ionis Pharmaceuticals (NAS:IONS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ionis Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ionis Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ionis Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Ionis Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Ionis Pharmaceuticals (Ionis Pharmaceuticals) Business Description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IONS has been successfully added to your 